CVR number 34700605
Industry 35.2100 Manufacture of gas

HORSENS BIOENERGI ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.9% 2.1% 2.1% 0.6% 2.1%  
Credit score (0-100)  45 67 65 97 66  
Credit rating  BBB A BBB AA BBB  
Credit limit (kDKK)  0.0 2.6 4.3 11,055.8 2.9  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  0 0 0 0 0  
Gross profit  21,281 39,674 64,363 71,062 7,621  
EBITDA  -690 14,090 37,401 66,106 1,288  
EBIT  -690 14,090 37,401 55,485 -12,862  
Pre-tax profit (PTP)  -2,683.0 8,420.0 27,133.0 53,972.7 -18,520.9  
Net earnings  -2,683.0 8,420.0 27,133.0 41,843.8 -14,446.7  
Pre-tax profit without non-rec. items  -690 14,090 37,401 53,973 -18,521  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Tangible assets total  0.0 0.0 0.0 243,470 231,043  
Shareholders equity total  20,993 29,413 56,546 76,390 61,943  
Interest-bearing liabilities  0.0 0.0 0.0 195,117 272,400  
Balance sheet total (assets)  160,555 159,598 237,153 316,972 370,805  
Net Debt  0.0 0.0 0.0 195,113 272,400  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  21,281 39,674 64,363 71,062 7,621  
Gross profit growth  -36.5% 86.4% 62.2% 10.4% -89.3%  
Employees  0 0 0 6 8  
Employee growth %  -100.0% 0.0% 0.0% 0.0% 33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  160,555 159,598 237,153 316,972 370,805  
Balance sheet change%  29.5% -0.6% 48.6% 33.7% 17.0%  
Added value  -690.0 14,090.0 37,401.0 55,485.1 1,287.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -98,798 -10,530 0 227,935 -21,312  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -3.2% 35.5% 58.1% 78.1% -168.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.5% 8.8% 18.9% 20.1% -3.4%  
ROI %  -0.5% 8.8% 18.9% 21.5% -3.7%  
ROE %  -12.0% 33.4% 63.1% 63.0% -20.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  100.0% 100.0% 100.0% 24.1% 16.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 295.2% 21,150.4%  
Gearing %  0.0% 0.0% 0.0% 255.4% 439.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 1.7% 3.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.4 1.3  
Current Ratio  0.0 0.0 0.0 0.4 1.3  
Cash and cash equivalent  0.0 0.0 0.0 3.8 0.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -118,877.2 35,271.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 9,248 161  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 11,018 161  
EBIT / employee  0 0 0 9,248 -1,608  
Net earnings / employee  0 0 0 6,974 -1,806